Plant expansins are structural cell wall-loosening proteins implicated in a number of developmental processes and responses to environmental constraints and pathogen an infection. To date, there may be restricted details about the organic operate of Expansins-like B (EXLBs), one of the smallest and less-studied subfamilies of plant expansins. In the current examine, we performed a useful evaluation of the wild Arachis AdEXLB8 gene in transgenic tobacco (Nicotiana tabacum) vegetation to make clear its putative position in mediating protection responses to abiotic and biotic stresses.
First, its cell wall localization was confirmed in vegetation expressing AdEXLB8:eGFP fusion, whereas nanomechanical assays indicated cell wall reorganization and reassembly due to AdEXLB8 overexpression with out compromising the phenotype. We additional demonstrated that AdEXLB8 elevated tolerance not solely to remoted abiotic (drought) and biotic (Sclerotinia sclerotiorum and Meloidogyne incognita) stresses but in addition to their mixture.
The jasmonate and abscisic acid signaling pathways have been clearly favored in transgenic vegetation, exhibiting an activated antioxidative protection system. In addition to modifications within the biomechanical properties of the cell wall, we suggest that AdEXLB8 overexpression interferes with phytohormone dynamics main to a protection primed state, which culminates in plant protection responses in opposition to remoted and mixed abiotic and biotic stresses.
Ddx20, DEAD field helicase 20, is crucial for the differentiation of oligodendrocyte and upkeep of myelin gene expression
Oligodendrocytes kind myelin sheaths that encompass axons, contributing to saltatory conduction and correct central nervous system (CNS) operate. Oligodendrocyte progenitor cells (OPCs) are generated in the course of the embryonic stage and differentiate into myelinating oligodendrocytes postnatally. Ddx20 is a multifunctional, DEAD-box helicase concerned in a number of mobile processes, together with transcription, splicing, microRNA biogenesis, and translation.
Although defects in every of these processes lead to irregular oligodendrocyte differentiation and myelination, the involvement of Ddx20 in oligodendrocyte terminal differentiation stays unknown. To tackle this query, we used Mbp-Cre mice to generate Ddx20 conditional knockout (cKO) mice to permit for the deletion of Ddx20 from mature oligodendrocytes. Mbp-Cre;Ddx20 cKO mice demonstrated small physique sizes, behavioral abnormalities, muscle weak point, and quick lifespans, with mortality by the age of 2 months outdated.
Histological analyses demonstrated vital reductions within the quantity of mature oligodendrocytes and drastic reductions within the expression ranges of myelin-associated mRNAs, similar to Mbp and Plp at postnatal day 42. The quantity of OPCs didn’t change. A skinny myelin layer was noticed for large-diameter axons in Ddx20 cKO mice, based mostly on electron microscopic evaluation.
A bromodeoxyuridine (BrdU) labeling experiment demonstrated that terminal differentiation was perturbed from ages 2 weeks to 7 weeks within the CNS of Mbp-Cre;Ddx20 cKO mice. The activation of mitogen-activated protein (MAP) kinase, which promotes myelination, was downregulated within the Ddx20 cKO mice based mostly on immunohistochemical detection. These outcomes point out that Ddx20 is an important issue for terminal differentiation of oligodendrocytes and upkeep of myelin gene expression.
SUMO Paralog Specific Functions Revealed via Systematic Analysis of Human Knockout Cell Lines and Gene Expression Data
The small ubiquitin-related modifiers (SUMOs) regulate practically each facet of mobile operate, from gene expression within the nucleus to ion transport on the plasma membrane. In people, the SUMO pathway has 5 SUMO paralogs with sequence homologies that vary from 45% to 97%. SUMO1 and SUMO2 are probably the most distantly associated paralogs, and additionally the perfect studied.
To what extent SUMO1, SUMO2 and the opposite paralogs impart distinctive and non-redundant results on mobile features, nonetheless, has not been systematically examined and is due to this fact not totally understood. For occasion, knockout research in mice have revealed conflicting necessities for the paralogs throughout improvement and research in cell tradition have relied largely on transient paralog overexpression or knockdown.
To tackle the prevailing hole in understanding, we first analyzed SUMO paralog gene expression ranges in regular human tissues and discovered distinctive patterns of SUMO1-3 expression throughout 30 tissue varieties, suggesting paralog-specific features in grownup human tissues. To systematically determine and characterize distinctive and non-redundant features of the SUMO paralogs in human cells, we subsequent used CRISPR-Cas9 to knock out SUMO1 and SUMO2 expression in osteosarcoma (U2OS) cells.
Analysis of these knockout cell traces revealed important features for SUMO1 and SUMO2 in regulating mobile morphology, PML nuclear physique construction, responses to proteotoxic and genotoxic stress, and management of gene expression. Collectively, our findings reveal non-redundant regulatory roles for SUMO1 and SUMO2 in controlling important mobile processes and present a foundation for extra exact SUMO-targeting therapies.

High-dimensional covariance matrices exams for analyzing multi-tumor gene expression information
By amassing a number of units per topic in microarray information, gene units evaluation requires characterize intra-subject variation utilizing gene expression profiling. For every topic, the info might be written as a matrix with the totally different subsets of gene expressions (e.g. a number of tumor varieties) indexing the rows and the genes indexing the columns.
Blunt E1 Expression Kit |
abx098098-10rxns |
Abbexa |
10 rxns |
EUR 560.4 |
|
Blunt E2 Expression Kit |
abx098873-10rxns |
Abbexa |
10 rxns |
EUR 560.4 |
|
RFP expression Adenovirus |
AVP001 |
GenTarget |
1x109 IFU/ml x 200ul |
EUR 418.8 |
Description: pre-made RFP expression adenovirus, provided in DMEM medium. |
CFP expression Adenovirus |
AVP002 |
GenTarget |
1x109 IFU/ml x 200ul |
EUR 418.8 |
Description: pre-made CFP expression adenovirus, provided in DMEM medium. |
GFP expression Adenovirus |
AVP011 |
GenTarget |
1x109 IFU/ml x 200ul |
EUR 418.8 |
Description: pre-made GFP expression adenovirus, provided in DMEM medium. |
YFP expression Adenovirus |
AVP012 |
GenTarget |
1x109 IFU/ml x 200ul |
EUR 418.8 |
Description: pre-made YFP expression adenovirus, provided in DMEM medium. |
BFP expression Adenovirus |
AVP017 |
GenTarget |
1x109 IFU/ml x 200ul |
EUR 418.8 |
Description: pre-made BFP expression adenovirus, provided in DMEM medium. |
h OCT4 expression Adenovirus, in vivo ready |
AVP013-PBS |
GenTarget |
1x1011 IFU/ml x 50ul |
EUR 852 |
Description: pre-made adenovirus express human stem cell factor, OCT4, provided in PBS solution for in vivo application. |
h SOX2 expression Adenovirus, in vivo ready |
AVP014-PBS |
GenTarget |
1x1011 IFU/ml x 50ul |
EUR 852 |
Description: pre-made adenovirus express human stem cell factor, SOX2, provided in PBS solution for in vivo application. |
h LIN28 expression Adenovirus, in vivo ready |
AVP015-PBS |
GenTarget |
1x1011 IFU/ml x 50ul |
EUR 852 |
Description: pre-made adenovirus express human stem cell factor, LIN28, provided in PBS solution for in vivo application. |
Rac1 Expression Vector Set |
STA-454 |
Cell Biolabs |
1 kit |
EUR 1765.2 |
Description: Rac1 Expression Vector Set contains 3 vectors: Rac wild type, T17N dominant negative mutant, and G12V constitutively active mutant. |
RhoA Expression Vector Set |
STA-456 |
Cell Biolabs |
1 kit |
EUR 1765.2 |
Description: RhoA Expression Vector Set contains 3 vectors: RhoA wild type, T19N dominant negative mutant, and G14V constitutively active mutant. |
Cdc42 Expression Vector Set |
STA-455 |
Cell Biolabs |
1 kit |
EUR 1765.2 |
Description: Cdc42 Expression Vector Set contains 3 vectors: Cdc42 wild type, T17N dominant negative mutant, and Q61L constitutively active mutant. |
h ADA Expression Lentivirus |
LVP923 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ADA, containing a RFP-Blasticidin dual selection marker. |
h IL6 Expression Lentivirus |
LVP1144 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h CD4 Expression Lentivirus |
LVP1152 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CD4, containing a RFP-Blasticidin dual selection marker. |
h IL4 Expression Lentivirus |
LVP1161 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL4, containing a RFP-Blasticidin dual selection marker. |
h IL7 Expression Lentivirus |
LVP1162 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL7, containing a RFP-Blasticidin dual selection marker. |
h KDR Expression Lentivirus |
LVP1176 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: KDR, containing a RFP-Blasticidin dual selection marker. |
h FAS Expression Lentivirus |
LVP1181 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: FAS, containing a RFP-Blasticidin dual selection marker. |
pAAV-MCS Expression Vector |
VPK-410 |
Cell Biolabs |
10 µg |
EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
h OCT4 expression Adenovirus |
AVP013 |
GenTarget |
1x109 IFU/ml x 200ul |
EUR 418.8 |
Description: pre-made adenovirus express human stem cell factor, OCT4, provided in DMEM medium. |
h SOX2 expression Adenovirus |
AVP014 |
GenTarget |
1x109 IFU/ml x 50ul |
EUR 418.8 |
Description: pre-made adenovirus express human stem cell factor, SOX2, provided in DMEM medium. |
h CDR1 Expression Lentivirus |
LVP917 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CDR1, containing a RFP-Blasticidin dual selection marker. |
h CD47 Expression Lentivirus |
LVP918 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CD47, containing a RFP-Blasticidin dual selection marker. |
h ESR1 Expression Lentivirus |
LVP924 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ESR1, containing a RFP-Blasticidin dual selection marker. |
r Syn1 Expression Lentivirus |
LVP925 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for rat target: Syn1, containing a RFP-Blasticidin dual selection marker. |
h NME4 Expression Lentivirus |
LVP932 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NME4, containing a RFP-Blasticidin dual selection marker. |
h EGFR Expression Lentivirus |
LVP1142 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: EGFR, containing a RFP-Blasticidin dual selection marker. |
h NRP1 Expression Lentivirus |
LVP1145 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h MUC1 Expression Lentivirus |
LVP1148 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h CD8a Expression Lentivirus |
LVP1151 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CD8a, containing a RFP-Blasticidin dual selection marker. |
h PIGF Expression Lentivirus |
LVP1154 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: PIGF, containing a RFP-Blasticidin dual selection marker. |
h BRAF Expression Lentivirus |
LVP1156 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: BRAF, containing a RFP-Blasticidin dual selection marker. |
h ROS1 Expression Lentivirus |
LVP1158 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ROS1, containing a RFP-Blasticidin dual selection marker. |
h CD3E Expression Lentivirus |
LVP1163 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL7, containing a RFP-Blasticidin dual selection marker. |
h KLK3 Expression Lentivirus |
LVP1171 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: KLK3, containing a RFP-Blasticidin dual selection marker. |
h NEK6 Expression Lentivirus |
LVP1182 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NEK6, containing a RFP-Blasticidin dual selection marker. |
h NEK7 Expression Lentivirus |
LVP1183 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NEK7, containing a RFP-Blasticidin dual selection marker. |
h LIN28 expression Adenovirus |
AVP015 |
GenTarget |
1x109 IFU/ml x 200ul |
EUR 418.8 |
Description: pre-made adenovirus express human stem cell factor, LIN28, provided in DMEM medium. |
h GPNMB Expression Lentivirus |
LVP921 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: GPNMB, containing a RFP-Blasticidin dual selection marker. |
h DECR1 Expression Lentivirus |
LVP927 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: DECR1, containing a RFP-Blasticidin dual selection marker. |
h DECR2 Expression Lentivirus |
LVP928 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: DECR2, containing a RFP-Blasticidin dual selection marker. |
h NMRK1 Expression Lentivirus |
LVP930 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NMRK1, containing a RFP-Blasticidin dual selection marker. |
h PITX3 Expression Lentivirus |
LVP931 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: PITX3, containing a RFP-Blasticidin dual selection marker. |
h HDAC1 Expression Lentivirus |
LVP1143 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h VEGFB Expression Lentivirus |
LVP1146 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h PARP1 Expression Lentivirus |
LVP1149 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h IL3RA Expression Lentivirus |
LVP1150 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL3RA, containing a RFP-Blasticidin dual selection marker. |
h PTCH1 Expression Lentivirus |
LVP1155 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: PTCH1, containing a RFP-Blasticidin dual selection marker. |
h SART3 Expression Lentivirus |
LVP1159 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: SART3, containing a RFP-Blasticidin dual selection marker. |
h TIGIT Expression Lentivirus |
LVP1160 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: TIGIT, containing a RFP-Blasticidin dual selection marker. |
h EDNRA Expression Lentivirus |
LVP1165 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: EDNRA containing a RFP-Blasticidin dual selection marker. |
h Foxp3 Expression Lentivirus |
LVP1172 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: Foxp3, containing a RFP-Blasticidin dual selection marker. |
m RIKEN Expression Lentivirus |
LVP1174 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for mouse target: RIKEN, containing a RFP-Blasticidin dual selection marker. |
h APLP2 Expression Lentivirus |
LVP1177 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: APLP2, containing a RFP-Blasticidin dual selection marker. |
h PCSK9 Expression Lentivirus |
LVP1178 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: PCSK9, containing a RFP-Blasticidin dual selection marker. |
h NTSR1 Expression Lentivirus |
LVP1179 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NTSR1, containing a RFP-Blasticidin dual selection marker. |
pscAAV-MCS Expression Vector |
VPK-430 |
Cell Biolabs |
10 µg |
EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
H-Ras Expression Vector Set |
STA-457 |
Cell Biolabs |
1 kit |
EUR 1765.2 |
Description: H-Ras Expression Vector Set contains 3 vectors: H-Ras wild type, T19N dominant negative mutant, and G12V constitutively active mutant. |
m CTAGA1 Expression Lentivirus |
LVP916 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for mouse target: CTAGA1, containing a RFP-Blasticidin dual selection marker. |
h SKIV2L Expression Lentivirus |
LVP919 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: SKIV2L, containing a RFP-Blasticidin dual selection marker. |
h SKIV2L Expression Lentivirus |
LVP919-GP |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: SKIV2L, containing a GFP-Puromycin dual selection marker. |
h TP5313 Expression Lentivirus |
LVP926 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: TP5313, containing a RFP-Blasticidin dual selection marker. |
h ELOVL5 Expression Lentivirus |
LVP929 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: ELOVL5, containing a RFP-Blasticidin dual selection marker. |
h MAGEA3 Expression Lentivirus |
LVP1147 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: HDAC1, containing a RFP-Blasticidin dual selection marker. |
h NANOS3 Expression Lentivirus |
LVP1164 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: NANOS3, containing a RFP-Blasticidin dual selection marker. |
h IL1RL1 Expression Lentivirus |
LVP1168 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: IL1RL1, containing a RFP-Blasticidin dual selection marker. |
h CTAG1B Expression Lentivirus |
LVP1169 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CTAG1B, containing a RFP-Blasticidin dual selection marker. |
h MAGEA3 Expression Lentivirus |
LVP1170 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: MAGEA3, containing a RFP-Blasticidin dual selection marker. |
h COX7A1 Expression Lentivirus |
LVP1173 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: COX7A1, containing a RFP-Blasticidin dual selection marker. |
h BCL11B Expression Lentivirus |
LVP1180 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: BCL11B, containing a RFP-Blasticidin dual selection marker. |
BRAF, His-Tag (High Expression) |
41237 |
BPS Bioscience |
10 µg |
EUR 375 |
Description: Human BRAF, also known as B-RAF1 and RAFB1, with 18 mutations to improve expression; S446A, S447A, I543A, I544S, I551K, Q562R, L588N, K630S, F667E, Y672S, A688R, L706S, Q709R, S713E, L716E, S720E, P722S, K723G. GenBank Accession #NM_004333, a.a. 444-723 with N-terminal His-tag, expressed in E. coli cells. MW = 33 kDa. |
ANPRA/Aequorin Expression vector |
60641 |
BPS Bioscience |
20 µg |
EUR 900 |
Description: The ANPRA/Aequorin expression vector is designed to co-express human atrial natriuretic peptide receptor A (ANPRA, also called natriuretic peptide receptor A/guanylate cyclase A) and jellyfish (Aequorea victoria) Aequorin in mammalian cells. |
h CEACAM5 Expression Lentivirus |
LVP1153 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: CEACAM5, containing a RFP-Blasticidin dual selection marker. |
h TNFSF11 Expression Lentivirus |
LVP1157 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: TNFSF11, containing a RFP-Blasticidin dual selection marker. |
h TNFRSF1B Expression Lentivirus |
LVP922 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: TNFRSF1B, containing a RFP-Blasticidin dual selection marker. |
h KIAA1324 Expression Lentivirus |
LVP1175 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: KIAA1324, containing a RFP-Blasticidin dual selection marker. |
GFP-Rac1 Expression Vector Set |
STA-450 |
Cell Biolabs |
1 kit |
EUR 1939.2 |
Description: GFP-Rac1 Expression Vector Set contains 3 vectors: Rac wild type, T17N dominant negative mutant, and Q61L constitutively active mutant. Each vector also contains a GFP reporter sequence. |
GFP-RhoA Expression Vector Set |
STA-452 |
Cell Biolabs |
1 kit |
EUR 1939.2 |
Description: GFP-RhoA Expression Vector Set contains 3 vectors: RhoA wild type, T19N dominant negative mutant, and Q63L constitutively active mutant. Each vector also contains a GFP reporter sequence. |
h KIAA0319L Expression Lentivirus |
LVP920 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for human target: KIAA0319L, containing a RFP-Blasticidin dual selection marker. |
GFP-Cdc42 Expression Vector Set |
STA-451 |
Cell Biolabs |
1 kit |
EUR 1939.2 |
Description: GFP-Cdc42 Expression Vector Set contains 3 vectors: Cdc42 wild type, T17N dominant negative mutant, and Q61L constitutively active mutant. Each vector also contains a GFP reporter sequence. |
Active Rac1 Expression Vector Set |
STA-458 |
Cell Biolabs |
1 kit |
EUR 1765.2 |
Description: Active Rac1 Expression Vector Set contains 3 vectors expressing different constitutively active mutants of Rac1: Q61L, Q61L/F37A, and Q61L/Y40C. |
PhiC31 Integrase Expression Plasmid |
FC200PA-1 |
SBI |
10ug |
EUR 496 |
pCMV-GFP-LC3 Expression Vector |
CBA-401 |
Cell Biolabs |
100 µL |
EUR 1243.2 |
Description: Expression vector contains a fusion of GFP and LC3. A separate GFP control vector is also included. |
h KRAS (G12D) Expression Lentivirus |
LVP1166 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for a mutant (G12D) of human target: KRAS containing a RFP-Blasticidin dual selection marker. |
h TP53 (R175H) Expression Lentivirus |
LVP1167 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for a mutant R175H) of human target: TP53, containing a RFP-Blasticidin dual selection marker. |
pAAV-IRES-Neo Expression Vector |
VPK-416 |
Cell Biolabs |
10 µg |
EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
pAAV-IRES-GFP Expression Vector |
VPK-418 |
Cell Biolabs |
10 µg |
EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
pAAV-IRES-Bsd Expression Vector |
VPK-419 |
Cell Biolabs |
10 µg |
EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
PinPoint Integrase Expression Plasmid |
PIN200A-1 |
SBI |
10ug |
EUR 688 |
pAAV-IRES-Puro Expression Vector |
VPK-415 |
Cell Biolabs |
10 µg |
EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
CEACAM5 CHO Cell Line (Low Expression) |
78704-L |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human CEACAM5 (NM_004363). Surface expression of CEACAM5 was confirmed by flow cytometry. The stable clonal cell line was selected for different levels of CEACAM5 expression (High, Medium, and Low) compared to the parental CHO-K1 cell line. |
Active H-Ras Expression Vector Set |
STA-459 |
Cell Biolabs |
1 kit |
EUR 1765.2 |
Description: Active H-Ras Expression Vector Set contains 3 vectors expressing different constitutively active mutants of H-Ras: V12, V12S35, and V12C40. |
B7-H3 CHO Cell Line (Low Expression) |
78541-L |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: B7 homolog 3 protein (B7-H3) CHO Cell line is a recombinant clonal stable CHO cell line expressing full length human B7-H3 protein, also known as cluster of differentiation 276 (CD276, B7H3; B7RP-2; 4Ig-B7-H3). Surface expression of B7-H3 was confirmed by flow cytometry. Each stable clonal cell line was selected for High, Medium, or Low levels of B7-H3 expression to mimic different B7-H3 expression levels in various cancer types. |
pAAV-IRES-Hygro Expression Vector |
VPK-417 |
Cell Biolabs |
10 µg |
EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
CD36 HEK293 Cell Line (High Expression) |
78526-H |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal HEK293 cell line stably expressing full length human CD36. The stable clonal cell line was selected for medium and high levels of CD36 expression compared to the parental HEK293 cell line. |
CEACAM5 CHO Cell Line (High Expression) |
78704-H |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human CEACAM5 (NM_004363). Surface expression of CEACAM5 was confirmed by flow cytometry. The stable clonal cell line was selected for different levels of CEACAM5 expression (High, Medium, and Low) compared to the parental CHO-K1 cell line. |
AAV-1 Helper Free Expression System |
VPK-410-SER1 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
AAV-2 Helper Free Expression System |
VPK-410-SER2 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
AAV-3 Helper Free Expression System |
VPK-410-SER3 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
AAV-4 Helper Free Expression System |
VPK-410-SER4 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
AAV-5 Helper Free Expression System |
VPK-410-SER5 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
AAV-6 Helper Free Expression System |
VPK-410-SER6 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
B7-H3 CHO Cell Line (High Expression) |
78541-H |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: B7 homolog 3 protein (B7-H3) CHO Cell line is a recombinant clonal stable CHO cell line expressing full length human B7-H3 protein, also known as cluster of differentiation 276 (CD276, B7H3; B7RP-2; 4Ig-B7-H3). Surface expression of B7-H3 was confirmed by flow cytometry. Each stable clonal cell line was selected for High, Medium, or Low levels of B7-H3 expression to mimic different B7-H3 expression levels in various cancer types. |
AAV-DJ Helper Free Expression System |
VPK-410-DJ |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). AAV Helper Free Complete Expression Systems are available for native serotypes 1 through 6, as well as the novel AAV-DJ and AAV-DJ/8. The AAV-DJ system provides a hybrid capsid created by DNA shuffling technology combining 8 different native serotypes: AAV-2, AAV-4, AAV-5, AAV-8, AAV-9, avian AAV, bovine AAV, and caprine AAV. The result is a highly infectious vector that can transduce a wide variety of cells and tissues at significantly higher rates than AAV-2. |
Gryphon Retroviral Expression System I |
ABP-RVK-10001 |
Allele Biotech |
1 set |
Ask for price |
|
Description: PRODUCT LINE DISCONTINUED. Please contact us. |
Gryphon Retroviral Expression System II |
ABP-RVK-10002 |
Allele Biotech |
1 set |
Ask for price |
|
Description: PRODUCT LINE DISCONTINUED. Please contact us. |
CD7 CHO Cell Line (Medium or High Expression)-78324-H |
78324-H |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant CD7 CHO-K1 cell lines expressing full-length human CD7 receptor (accession number: NM_006137.6). Surface expression of human CD7 was confirmed by flow cytometry. Each stable clonal cell line was selected for high or medium levels of CD7 expression to mimic different stages of cancer target cells with various CD7 expression levels. |
CD7 CHO Cell Line (Medium or High Expression)-78324-M |
78324-M |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant CD7 CHO-K1 cell lines expressing full-length human CD7 receptor (accession number: NM_006137.6). Surface expression of human CD7 was confirmed by flow cytometry. Each stable clonal cell line was selected for high or medium levels of CD7 expression to mimic different stages of cancer target cells with various CD7 expression levels. |
CD36 HEK293 Cell Line (Medium Expression) |
78526-M |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal HEK293 cell line stably expressing full length human CD36. The stable clonal cell line was selected for medium and high levels of CD36 expression compared to the parental HEK293 cell line. |
CEACAM5 CHO Cell Line (Medium Expression) |
78704-M |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human CEACAM5 (NM_004363). Surface expression of CEACAM5 was confirmed by flow cytometry. The stable clonal cell line was selected for different levels of CEACAM5 expression (High, Medium, and Low) compared to the parental CHO-K1 cell line. |
Human Myelin expression factor 2 (MYEF2) |
1-CSB-EP015283HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Myelin expression factor 2(MYEF2),partial expressed in E.coli |
scAAV-1 Helper Free Expression System |
VPK-430-SER1 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
scAAV-2 Helper Free Expression System |
VPK-430-SER2 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
scAAV-3 Helper Free Expression System |
VPK-430-SER3 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
scAAV-4 Helper Free Expression System |
VPK-430-SER4 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
scAAV-5 Helper Free Expression System |
VPK-430-SER5 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
scAAV-6 Helper Free Expression System |
VPK-430-SER6 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). |
B7-H3 CHO Cell Line (Medium Expression) |
78541-M |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: B7 homolog 3 protein (B7-H3) CHO Cell line is a recombinant clonal stable CHO cell line expressing full length human B7-H3 protein, also known as cluster of differentiation 276 (CD276, B7H3; B7RP-2; 4Ig-B7-H3). Surface expression of B7-H3 was confirmed by flow cytometry. Each stable clonal cell line was selected for High, Medium, or Low levels of B7-H3 expression to mimic different B7-H3 expression levels in various cancer types. |
CD95 CHO Cell Line (Medium or High Expression)-78499-H |
78499-H |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: The CD95 CHO cell line is a recombinant clonal stable CHO cell line constitutively expressing full-length human CD95 receptor (accession number: NM_000043.3). Surface expression of human CD95 was confirmed by flow cytometry. Each clonal cell line was selected for different levels of CD95 expression (High or Medium) to mimic varying CD95 expression levels in cancer cells. |
CD95 CHO Cell Line (Medium or High Expression)-78499-M |
78499-M |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: The CD95 CHO cell line is a recombinant clonal stable CHO cell line constitutively expressing full-length human CD95 receptor (accession number: NM_000043.3). Surface expression of human CD95 was confirmed by flow cytometry. Each clonal cell line was selected for different levels of CD95 expression (High or Medium) to mimic varying CD95 expression levels in cancer cells. |
Protein Limb Expression 1 (LIX1) Antibody |
20-abx318393 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Protein Limb Expression 1 (LIX1) Antibody |
abx146234-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
Protein Limb Expression 1 (LIX1) Antibody |
abx025913-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Protein Limb Expression 1 (LIX1) Antibody |
abx025913-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
scAAV-DJ Helper Free Expression System |
VPK-430-DJ |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). AAV Helper Free Complete Expression Systems are available for native serotypes 1 through 6, as well as the novel AAV-DJ and AAV-DJ/8. The AAV-DJ system provides a hybrid capsid created by DNA shuffling technology combining 8 different native serotypes: AAV-2, AAV-4, AAV-5, AAV-8, AAV-9, avian AAV, bovine AAV, and caprine AAV. The result is a highly infectious vector that can transduce a wide variety of cells and tissues at significantly higher rates than AAV-2. |
pRedPuro shRNA expression lentivector (EF1) |
SI516A-1 |
SBI |
10 ug |
EUR 594 |
pAAV-MCS Promoterless Expression Vector |
VPK-411 |
Cell Biolabs |
10 µg |
EUR 776.4 |
Description: Clone your gene of interest into this AAV Expression Vector, then co-transfect along with AAV packaging vectors into a packaging host cell line such as 293AAV. |
pSMPUW-Neo Lentiviral Expression Vector |
VPK-213 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
Claudin-6 CHO Cell Line (Low Expression) |
78527-L |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human claudin-6 (CLDN6 gene accession number NM_021195.5). Surface expression of claudin 6 was confirmed by flow cytometry. The stable clonal cell line was selected for high, medium, or low levels of claudin-6 expression compared to the parental CHO-K1 cell line. |
RAPAd® RSV Adenoviral Expression System |
VPK-251 |
Cell Biolabs |
1 kit |
EUR 1243.2 |
Description: Making an adenovirus with traditional recombinant methods takes 2-3 months and requires tedious plaque recombination. More recent technologies have shortened this time somewhat, but still produce relatively high amounts of wild type (replication-competent) plaques, levels of which increase with serial amplification. The RAPAd® Adenoviral Expression Systems produce recombinant adenovirus with substantially reduced wild-type virus, while considerably shortening the production time to 2-3 weeks. Serial amplification of adenovirus produced using the RAPAd® system does not significantly increase replication-competent adenovirus levels. The system uses a backbone vector from which the 5' ITR, packaging signal and E1 sequences have been removed. |
RAPAd® CMV Adenoviral Expression System |
VPK-252 |
Cell Biolabs |
1 kit |
EUR 1243.2 |
Description: Making an adenovirus with traditional recombinant methods takes 2-3 months and requires tedious plaque recombination. More recent technologies have shortened this time somewhat, but still produce relatively high amounts of wild type (replication-competent) plaques, levels of which increase with serial amplification. The RAPAd® Adenoviral Expression Systems produce recombinant adenovirus with substantially reduced wild-type virus, while considerably shortening the production time to 2-3 weeks. Serial amplification of adenovirus produced using the RAPAd® system does not significantly increase replication-competent adenovirus levels. The system uses a backbone vector from which the 5' ITR, packaging signal and E1 sequences have been removed. |
pSMPUW-Puro Lentiviral Expression Vector |
VPK-212 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
Claudin-6 CHO Cell Line (High Expression) |
78527-H |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human claudin-6 (CLDN6 gene accession number NM_021195.5). Surface expression of claudin 6 was confirmed by flow cytometry. The stable clonal cell line was selected for high, medium, or low levels of claudin-6 expression compared to the parental CHO-K1 cell line. |
AAV-DJ/8 Helper Free Expression System |
VPK-410-DJ-8 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). AAV Helper Free Complete Expression Systems are available for native serotypes 1 through 6, as well as the novel AAV-DJ and AAV-DJ/8. The AAV-DJ system provides a hybrid capsid created by DNA shuffling technology combining 8 different native serotypes: AAV-2, AAV-4, AAV-5, AAV-8, AAV-9, avian AAV, bovine AAV, and caprine AAV. The result is a highly infectious vector that can transduce a wide variety of cells and tissues at significantly higher rates than AAV-2. AAV-DJ/8 was created by making a point mutation in the heparin binding domain of AAV-DJ. Recombinant AAV produced from the AAV-DJ/8 system closely resembles AAV-8 and AAV-9 in its ability to infect heart and brain tissues. |
Myelin Expression Factor 2 (MYEF2) Antibody |
abx235464-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Myelin Expression Factor 2 (MYEF2) Antibody |
20-abx109333 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Myelin Expression Factor 2 (MYEF2) Antibody |
20-abx113906 |
Abbexa |
|
|
|
Expression Negative Control Lentivirus (G418) |
79902-G |
BPS Bioscience |
500 µl x 2 |
EUR 795 |
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_ |
pGreenPuro shRNA expression lentivector (CMV) |
SI505A-1 |
SBI |
10 ug |
EUR 594 |
pGreenPuro shRNA expression lentivector (EF1) |
SI506A-1 |
SBI |
10 ug |
EUR 594 |
pSMPUW-Hygro Lentiviral Expression Vector |
VPK-214 |
Cell Biolabs |
10 µg |
EUR 748.8 |
Description: Clone your gene of interest into this Lentiviral Expression Vector, then co-transfect along with lentiviral packaging vectors into a packaging cell line such as 293LTV. This expression vector is compatible with any 2nd or 3rd generation lentiviral packaging system, but due to its design it is best matched with our ViraSafe packaging vectors to produce the highest viral titer. |
Baculovirus expression vector pAc-g-CH3 |
30R-AB001 |
Fitzgerald |
5 ug |
EUR 739.2 |
Description: Baculovirus cassette vector pAc-l-CH3 for the expression of human, humanized or chimeric IgG(lambda) in insect cells and secretion of assembled antibodies into the supernatant. |
RAPAd® miRNA Adenoviral Expression System |
VPK-253 |
Cell Biolabs |
1 kit |
EUR 1243.2 |
Description: Making an adenovirus with traditional recombinant methods takes 2-3 months and requires tedious plaque recombination. More recent technologies have shortened this time somewhat, but still produce relatively high amounts of wild type (replication-competent) plaques, levels of which increase with serial amplification. The RAPAd® Adenoviral Expression Systems produce recombinant adenovirus with substantially reduced wild-type virus, while considerably shortening the production time to 2-3 weeks. Serial amplification of adenovirus produced using the RAPAd® system does not significantly increase replication-competent adenovirus levels. The system uses a backbone vector from which the 5' ITR, packaging signal and E1 sequences have been removed. |
Claudin-6 CHO Cell Line (Medium Expression) |
78527-M |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal CHO cell line stably expressing full-length human claudin-6 (CLDN6 gene accession number NM_021195.5). Surface expression of claudin 6 was confirmed by flow cytometry. The stable clonal cell line was selected for high, medium, or low levels of claudin-6 expression compared to the parental CHO-K1 cell line. |
scAAV-DJ/8 Helper Free Expression System |
VPK-430-DJ-8 |
Cell Biolabs |
1 kit |
EUR 1486.8 |
Description: The AAV Helper Free System produces recombinant AAV containing your gene of interest without the need to use a helper adenovirus. The adenoviral genes required for proper AAV packaging are provided in the pHelper plasmid (E2A, E4 and VA RNA) or in the 293 packaging cells (E1). AAV Helper Free Complete Expression Systems are available for native serotypes 1 through 6, as well as the novel AAV-DJ and AAV-DJ/8. The AAV-DJ system provides a hybrid capsid created by DNA shuffling technology combining 8 different native serotypes: AAV-2, AAV-4, AAV-5, AAV-8, AAV-9, avian AAV, bovine AAV, and caprine AAV. The result is a highly infectious vector that can transduce a wide variety of cells and tissues at significantly higher rates than AAV-2. AAV-DJ/8 was created by making a point mutation in the heparin binding domain of AAV-DJ. Recombinant AAV produced from the AAV-DJ/8 system closely resembles AAV-8 and AAV-9 in its ability to infect heart and brain tissues. |
pC001 - huLshC2C2- MBP for bacterial expression |
PVT10645 |
Lifescience Market |
2 ug |
EUR 361.2 |
Exoenzyme C3 (Rho Inhibitor) Expression Vector |
STA-460 |
Cell Biolabs |
1 kit |
EUR 860.4 |
Description: This mammalian expression vector codes for Exoenzyme C3, a Rho inhibitor. |
Protein Limb Expression 1 (LIX1) Antibody (HRP) |
20-abx308975 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
LEXSYcon2.1 Expression Kit M-EGE-1310ble ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
M-EGE-1310ble |
MiTeGen |
1 Kit |
EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310ble ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
LEXSYcon2.1 Expression Kit M-EGE-1310bsd ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
M-EGE-1310bsd |
MiTeGen |
1 Kit |
EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310bsd ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
LEXSYcon2.1 Expression Kit M-EGE-1310hyg ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
M-EGE-1310hyg |
MiTeGen |
1 Kit |
EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310hyg ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
LEXSYcon2.1 Expression Kit M-EGE-1310neo ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
M-EGE-1310neo |
MiTeGen |
1 Kit |
EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310neo ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
LEXSYcon2.1 Expression Kit M-EGE-1310pac ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
M-EGE-1310pac |
MiTeGen |
1 Kit |
EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310pac ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
LEXSYcon2.1 Expression Kit M-EGE-1310sat ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
M-EGE-1310sat |
MiTeGen |
1 Kit |
EUR 1682 |
Description: LEXSYcon2.1 Expression Kit M-EGE-1310sat ** shipped on blue ice/Dry Ice (two separate boxes) - must be shipped overnight |
Cre Recombinase Expression Plasmid (pCMV-CRE) |
CRE100A-1 |
SBI |
10 µg |
EUR 412 |
Flp recombinase expression HEK293 stable cell |
SC006 |
GenTarget |
2 x 106 cell/ml x 1ml |
EUR 2670 |
Description: Flp recombinase stable cell line with Blasticidin resistance |
Recombinant DNA expression in Pichia pastoris |
HESAP-1002-10G |
Cyagen |
10G |
EUR 2250 |
BCMA CHO Recombinant Cell Line (Low Expression) |
79500-L |
BPS Bioscience |
2 vials |
EUR 6500 |
Description: Recombinant clonal stable CHO cell line constitutively expressing full length human BCMA protein, also known as TNFRSF17, (Genbank #NM_001192). Surface expression of BCMA was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of BCMA expression, (H. M, L), to mimic different stages of cancer target cells with various BCMA expression levels. |
CD19 CHO Recombinant Cell Line (Low Expression) |
79561-L |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal stable CHO cell line constitutively expressing full length human CD19 protein, also known as B4 or CVID3, (Genbank #NM_001770). Surface expression of CD19 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD19 expression (High, Medium, Low) to mimic different stages of cancer target cells with various CD19 expression levels. |
CD37/CHO Recombinant Cell Line (Low Expression) |
79607-L |
BPS Bioscience |
2 vials |
EUR 6500 |
Description: Recombinant clonal stable CHO cell line constitutively expressing full length human CD37 protein, also known as GP52-40; TSPAN26; leukocyte antigen CD37 (Genbank #NM_001774). Surface expression of CD37 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD37 expression, (High, Medium, Low), to mimic different stages of cancer target cells with various CD37 expression levels. |
CD38 CHO Recombinant Cell Line (Low Expression) |
79615-L |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal stable CHO cell line constitutively expressing full length human CD20 protein, also known as MS4A1 (Genbank #NM_152866). Surface expression of CD20 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD20 expression (High, Medium) to mimic different stages of cancer target cells with various CD20 expression levels. |
Protein Limb Expression 1 (LIX1) Antibody (FITC) |
20-abx308976 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Platinum Retroviral Expression System, Ecotropic |
VPK-300 |
Cell Biolabs |
1 kit |
EUR 1402.8 |
Description: Retroviral vectors are useful for delivering genes of interest into a target cells where integration into the genome is desired. However, traditional retroviral expression technologies result in low viral titers, making gene expression studies challenging. Platinum Retroviral Expression Systems incorporate superior packaging cell lines and vector technologies to produce high-titer virus with a single plasmid transfection. This system includes our exclusive Platinum-E Packaging cell line, which contains the gag and pol genes and an ecotropic envelope protein for viral packaging. Simply clone your gene of interest into the vector provided and transfect into the packaging cells. |
Platinum Retroviral Expression System, Pantropic |
VPK-302 |
Cell Biolabs |
1 kit |
EUR 1402.8 |
Description: Retroviral vectors are useful for delivering genes of interest into a target cells where integration into the genome is desired. However, traditional retroviral expression technologies result in low viral titers, making gene expression studies challenging. Platinum Retroviral Expression Systems incorporate superior packaging cell lines and vector technologies to produce high-titer virus with a single plasmid transfection. This system includes our exclusive Platinum-GP Packaging cell line which contains the gag and pol genes necessary for viral packaging. Simply clone your gene of interest into the vector provided and co-transfect into the packaging cells along with the included VSVG plasmid. |
BCMA CHO Recombinant Cell Line (High Expression) |
79500-H |
BPS Bioscience |
2 vials |
EUR 6500 |
Description: Recombinant clonal stable CHO cell line constitutively expressing full length human BCMA protein, also known as TNFRSF17, (Genbank #NM_001192). Surface expression of BCMA was confirmed by flow cytometry. |
CD22 CHO Recombinant Cell Line (High Expression) |
79557-H |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal stable CHO cell line constitutively expressing full length human CD22 protein (Genbank #NM_001771). Surface expression of CD22 was confirmed by flow cytometry. This clonal cell line was selected for medium level expression of CD22. A clone exhibiting higher levels of CD22 expression is also available (#79557-M). Please contact BPS Bioscience for additional information. |
CD19 CHO Recombinant Cell Line (High Expression) |
79561-H |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal stable CHO cell line constitutively expressing full length human CD19 protein, also known as B4 or CVID3, (Genbank #NM_001770). Surface expression of CD19 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD19 expression (High, Medium, Low) to mimic different stages of cancer target cells with various CD19 expression levels. |
CD37/CHO Recombinant Cell Line (High Expression) |
79607-H |
BPS Bioscience |
2 vials |
EUR 6500 |
Description: Recombinant clonal stable CHO cell line constitutively expressing full length human CD37 protein, also known as GP52-40; TSPAN26; leukocyte antigen CD37 (Genbank #NM_001774). Surface expression of CD37 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD37 expression, (High, Medium, Low), to mimic different stages of cancer target cells with various CD37 expression levels. |
CD38 CHO Recombinant Cell Line (High Expression) |
79615-H |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal stable CHO cell line constitutively expressing full length human CD20 protein, also known as MS4A1 (Genbank #NM_152866). Surface expression of CD20 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD20 expression (High, Medium) to mimic different stages of cancer target cells with various CD20 expression levels. |
CD20 CHO Recombinant Cell Line (High Expression) |
79624-H |
BPS Bioscience |
2 vials |
EUR 7150 |
Description: Recombinant clonal stable CHO cell line constitutively expressing full length human CD20 protein, also known as MS4A1 (Genbank #NM_152866). Surface expression of CD20 was confirmed by flow cytometry. Each stable clonal cell line was selected for different levels of CD20 expression (High, Medium) to mimic different stages of cancer target cells with various CD20 expression levels. |
Myelin Expression Factor 2 (MYEF2) Antibody (HRP) |
20-abx108522 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
PD-L1 / TCR Activator Mammalian Expression Kit |
60610 |
BPS Bioscience |
500 rxns. |
EUR 590 |
Description: The recombinant expression vectors are designed to express human engineered T cell receptor (TCR) activator and human PD-L1 (GenBank Accession #NM_014143) in mammalian cells. The transfected cells can be used in conjunction with PD-1/NFAT Reporter/Jurkat T cells (BPS #60535) to study the interactions of PD-1 with PD-L1 ligand in a cellular context and screen for modulators of this signaling pathway._x000D_In this assay, PD-1/NFAT Reporter/Jurkat T cells are used as effector cells; HEK293 cells overexpressing PD-L1 (or PD-L2) and an engineered T cell receptor (TCR) activator are used as target cells. When these two cells are co-cultivated, TCR complexes on effector cells are activated by TCR activator on target cells, resulting in expression of the NFAT luciferase reporter. However, PD1 and PD-L1 (or PD-L2) ligation prevents TCR activation and suppresses the NFAT-responsive luciferase activity. This inhibition can be specifically reversed by anti-PD1 or anti-PD-L1 antibodies. PD1/PD-L1 neutralizing antibodies block PD1:PD-L1 interaction and promote T cell activation, resulting in reactivation of the NFAT responsive luciferase reporter. |
PD-L2 / TCR Activator Mammalian Expression Kit |
60620 |
BPS Bioscience |
500 rxns. |
EUR 565 |
Description: The recombinant expression vectors are designed to express human engineered T cell receptor (TCR) activator and human PD-L2 (GenBank Accession #NM_025239) in mammalian cells. The transfected cells can be used in conjunction with PD-1/NFAT Reporter/Jurkat T cells (BPS #60535) to study the interactions of PD-1 with PD-L2 ligand in a cellular context and screen for modulators of this signaling pathway._x000D_In this assay, PD-1/NFAT Reporter/Jurkat T cells are used as effector cells; HEK293 cells overexpressing PD-L1 (or PD-L2) and an engineered T cell receptor (TCR) activator are used as target cells. When these two cells are co-cultivated, TCR complexes on effector cells are activated by TCR activator on target cells, resulting in expression of the NFAT luciferase reporter. However, PD1 and PD-L1 or PD-L2 ligation prevents TCR activation and suppresses the NFAT-responsive luciferase activity. This inhibition can be specifically reversed by anti-PD1 or anti-PD-L1 antibodies. PD1, PD-L1, or PD-L2 neutralizing antibodies block PD1:PD-L1 and/or PD1:PD-L2 interaction and promote T cell activation, resulting in reactivation of the NFAT responsive luciferase reporter. |
h INS-IGF2 (GFP-Puro) Expression Lentivirus |
LVP699-GP |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
Description: Pre-made over-expression lentivirus for expressing human target: INS-IGF2 ( INS-IGF2 readthrough). It also contains a GFP-Puromycin dual selection marker. |
To check the belief of intra-subject (tumor) variation, we current and carry out exams of multi-set sphericity and multi-set identification of covariance buildings throughout topics (tumor varieties). We display by both theoretical and empirical research that the exams have good properties. We utilized the proposed exams on The Cancer Genome Atlas (TCGA) and examined covariance buildings for the gene expressions throughout a number of tumor varieties.